×
Stryker Cash on Hand 2010-2024 | SYK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Stryker cash on hand for the quarter ending September 30, 2024 was
$4.684B
, a
141.94% increase
year-over-year.
Stryker cash on hand for 2023 was
$3.053B
, a
58.35% increase
from 2022.
Stryker cash on hand for 2022 was
$1.928B
, a
36.14% decline
from 2021.
Stryker cash on hand for 2021 was
$3.019B
, a
0.17% decline
from 2020.
View More
Stryker Cash on Hand 2010-2024 | SYK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Stryker cash on hand for 2023 was
$3.053B
, a
58.35% increase
from 2022.
Stryker cash on hand for 2022 was
$1.928B
, a
36.14% decline
from 2021.
Stryker cash on hand for 2021 was
$3.019B
, a
0.17% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$204.2B
Boston Scientific (BSX)
$132.6B
EssilorLuxottica (ESLOY)
$112.1B
Medtronic (MDT)
$110.6B
Haleon (HLN)
$43.7B
Lonza Group Ag (LZAGY)
$42.2B
GE HealthCare Technologies (GEHC)
$37.7B
ResMed (RMD)
$35.8B
Terumo (TRUMY)
$29.7B
Koninklijke Philips (PHG)
$24.8B
Zimmer Biomet Holdings (ZBH)
$21.9B
Insulet (PODD)
$18.4B
Baxter (BAX)
$17B
Smith & Nephew SNATS (SNN)
$11.1B
BellRing Brands (BRBR)
$10.2B
Bio-Rad Laboratories (BIO)
$9.3B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$6.3B
TG Therapeutics (TGTX)
$5.5B
Haemonetics (HAE)
$4.3B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4.1B
Perrigo (PRGO)
$3.8B
Envista Holdings (NVST)
$3.7B
Neogen (NEOG)
$3.2B
Agios Pharmaceuticals (AGIO)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.8B
QuidelOrtho (QDEL)
$2.7B
LeMaitre Vascular (LMAT)
$2.4B